Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumour immunology.

B F Heslop

    The Australian and New Zealand Journal of Surgery
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Researchers explored tumor immunology, finding that while some experimental tumors express unique antigens and can be rejected by immune hosts, the mechanisms are unclear. Current evidence challenges the immunological surveillance theory, and clinical cancer immunotherapy remains largely empirical.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Runt Disease-II.

    British medical journal·2010
    Same author

    Where are tomorrow's specialists?

    The New Zealand medical journal·1995
    Same author

    Evidence that changes in expression of major histocompatibility complex antigens may underlie the immunosuppressive effect of heat-treated cells in vivo and in vitro.

    Transplantation·1992
    Same author

    Two methods of heterotopic heart grafting in rats compared.

    Transplantation·1991
    Same author

    Collapse curve clearance of transfused red blood cells in allogeneic rat strain combinations is a T-cell-dependent, but NK-independent phenomenon.

    Transplantation proceedings·1990
    Same author

    The urease ELISA for H-Y antibody. A cautionary tale.

    Journal of immunological methods·1990
    Same journal

    The Experimental Application of Microsurgical Techniques to Internal Mammary to Coronary Artery Anastomosis.

    The Australian and New Zealand journal of surgery·2018
    Same journal

    The Use of Trimethoprim-Sulphamethoxazole in the Treatment of Complicated Urinary Tract Infection.

    The Australian and New Zealand journal of surgery·2018
    Same journal

    The Bairnsdale Ulcer.

    The Australian and New Zealand journal of surgery·2018
    Same journal

    Aorto-Caval Fistula: Successful Management of Two Cases.

    The Australian and New Zealand journal of surgery·2018
    Same journal

    Subdural Empyema.

    The Australian and New Zealand journal of surgery·2018
    Same journal

    Massive Ascites Due to Pancreatic Stones.

    The Australian and New Zealand journal of surgery·2018
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Experimental Cancer Research

    Background:

    • Neoplastic cells can express unique antigens differentiating them from normal cells.
    • Experimental models show that specifically immunized hosts can reject small tumors.
    • The underlying mechanisms of tumor rejection and the immune system's role in cancer are not fully understood.

    Purpose of the Study:

    • To investigate the immunological aspects of tumor rejection.
    • To evaluate the influence of the immune system on neoplasia.
    • To assess the current status and potential of clinical cancer immunotherapy.

    Main Methods:

    • Identification of tumor-specific antigens in experimental models.
    • Immunization of hosts to assess tumor rejection.

    Related Experiment Videos

  • Review of existing literature on tumor immunology and immunotherapy.

    • Main Results:

    • Tumor-specific antigens are identifiable in some experimental tumors.
    • Immunologically mediated rejection of small tumors is possible in specific circumstances.
    • Mechanisms of tumor rejection remain largely unknown.
    • The concept of immunological surveillance against neoplasia is increasingly questioned.
    • Clinical cancer immunotherapy has shown limited success and is primarily empirical.

    Conclusions:

    • While tumor antigens and immune rejection exist in experimental settings, their mechanisms and relevance to human cancer require further investigation.
    • The role of the immune system in controlling neoplasia is complex and the theory of immunological surveillance is not strongly supported by current evidence.
    • Clinical cancer immunotherapy is still in its early, empirical stages with limited proven efficacy.